All about the base: New businesses eye the opportunities in managing genome data
By The Economist,
The Economist
| 06. 25. 2016
The project to understand the human genome has long promised to revolutionise the way that diseases are diagnosed, drugs are designed and even the way that medicine is practised. An ability to interpret human genetic information holds the promise of doing everything from predicting which drugs will work on a particular patient to identifying a person’s predisposition to develop diseases.
Genomic information is already transforming some medical practices. Sequencing has changed the way that fetuses are screened for Down’s syndrome, from a risky invasive test to one where abnormalities in fetal DNA can be picked up from blood drawn from the mother. In time this sort of method will extend to other genetic disorders and other medical applications. One area of promise is treating some types of cancer. Using blood tests to detect genetic changes in tumours could allow doctors to discover more quickly when drugs are no longer effective. This is so promising that there is already speculation that performing such “liquid” biopsies could be a $11 billion business by 2022.
Realising the vast potential of genomic medicine is...
Related Articles
Reproductive rights have been a flashpoint in national politics for decades, with the stakes surging after the Supreme Court shredded the right to an abortion. In the current presidential campaign, the battle over abortion has swelled and morphed to encompass in vitro fertilization (IVF), which has now moved rapidly from widely accepted to partisan hot button.
This dramatic shift was highlighted by the February decision of the Alabama Supreme Court that granted personhood rights to frozen IVF embryos, signaling that...
By Gabby Del Valle, The Baffler | 09.17.2024
IT’S A COMMON STORY, banal, even: a child of privilege, an heir apparent, leaves for college to get a good enough education—and maybe have a little fun—before taking over the family business. But the child, away from the nest for...
By Deirdre Walsh , NPR | 09.17.2024
Senate Republicans blocked a Democratic bill to provide a nationwide right to IVF treatments. It was the second time Senate Democrats tried and failed to advance the measure.
Reproductive freedom has remained a central issue in several Senate contests that...
By Ali Breland, The Atlantic | 08.20.2024
“Joining us now is Steve Sailer, who I find to be incredibly interesting, and one of the most talented noticers,” Charlie Kirk said on his internet show in October. Kirk, the 30-year-old founder of Turning Point USA, a right-wing...